Biorestorative Therapies (BRTX)
(Delayed Data from NSDQ)
$1.73 USD
+0.04 (2.37%)
Updated Oct 15, 2024 03:46 PM ET
After-Market: $1.73 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.50 |
Last EPS Surprise | 10.71% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.63 |
Next Year | -1.07 |
EPS (TTM) | -2.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.30M | 0.45M | 0.87M | 3.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.30M | 0.45M | 0.87M | 3.00M |
Low Estimate | 0.30M | 0.45M | 0.87M | 3.00M |
Year ago Sales | 0.03M | 0.02M | 0.15M | 0.87M |
Year over Year Growth Est. | 900.00% | 2,150.00% | 495.93% | 244.83% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.42 | -1.63 | -1.07 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.36 | -0.42 | -1.63 | -1.07 |
High Estimate | -0.36 | -0.42 | -1.63 | -1.07 |
Low Estimate | -0.36 | -0.42 | -1.63 | -1.07 |
Year ago EPS | -0.64 | -0.57 | -3.42 | -1.63 |
Year over Year Growth Est. | 43.75% | 26.32% | 52.34% | 34.36% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.42 | -1.63 | -1.07 |
7 Days Ago | -0.36 | -0.42 | -1.63 | -1.07 |
30 Days Ago | -0.36 | -0.42 | -1.63 | -1.07 |
60 Days Ago | -0.36 | -0.42 | -1.63 | -1.07 |
90 Days Ago | -0.63 | -0.59 | -2.16 | -1.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.42 | -1.63 | -1.07 |
Zacks Consensus Estimate | -0.36 | -0.42 | -1.63 | -1.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.50 | -0.53 | -0.57 | -0.64 | NA |
Estimate | -0.56 | -0.51 | -0.65 | -0.68 | NA |
Difference | 0.06 | -0.02 | 0.08 | 0.04 | 0.04 |
Surprise | 10.71% | -3.92% | 12.31% | 5.88% | 6.25% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more